Bloodstream infections - from threats to solutions

Vancouver, kelowna, and delta, british columbia--(newsfile corp. - july 11, 2024) - investorideas.com, a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring citius pharmaceuticals, inc. (nasdaq: ctxr), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. the company's diversified pipeline includes two late-stage product candidates.
CTXR Ratings Summary
CTXR Quant Ranking